HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 49217,
"recordsTotal": 49217,
"next": null,
"previous": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&ordering=days_late&start=48900",
"results": [
{
"registry_id": "NCT07431827",
"publication_url": "https://clinicaltrials.gov/study/NCT07431827",
"title": "A Phase 3, Randomized, Double-blind Study of Adjuvant MK-1084 Plus Subcutaneous Pembrolizumab and Berahyaluronidase Alfa (MK-3475A) Versus Adjuvant Placebo Plus MK-3475A in Participants With Completely Resected Stage IIA-IIIB (N2), KRAS G12C-mutant Non-small Cell Lung Cancer Following Receipt of Either Neoadjuvant Pembrolizumab Plus Chemotherapy or Adjuvant Chemotherapy (KANDLELIT-013)",
"has_exemption": false,
"start_date": "2026-03-18",
"completion_date": "2039-10-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02598349",
"publication_url": "https://clinicaltrials.gov/study/NCT02598349",
"title": "A Phase II Trial of Escalated Dose Proton Radiotherapy With Elective Nodal Irradiation and Concomitant Chemotherapy for Patients With Unresectable, Borderline Resectable or Medically Inoperable Pancreatic Adenocarcinoma",
"has_exemption": false,
"start_date": "2016-04-30",
"completion_date": "2039-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Proton Collaborative Group",
"sponsor_slug": "proton-collaborative-group",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06617286",
"publication_url": "https://clinicaltrials.gov/study/NCT06617286",
"title": "MAC-CAR: A Phase 1B/II Trial of Myeloablative Conditioning and Autologous Stem Cell Transplantation Followed by Autologous CD30+ CAR T Cells in Children, Adolescents and Young Adults With Poor-Risk Classical Hodgkin Lymphoma (cHL)",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2039-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "New York Medical College",
"sponsor_slug": "new-york-medical-college",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03007589",
"publication_url": "https://clinicaltrials.gov/study/NCT03007589",
"title": "Natural Sunlight Protection and Simulated Sunlight Protection Offered by Sunscreens and Fabrics",
"has_exemption": false,
"start_date": "2014-04-30",
"completion_date": "2040-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sun Protection Foundation",
"sponsor_slug": "sun-protection-foundation",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT05568719",
"publication_url": "https://clinicaltrials.gov/study/NCT05568719",
"title": "A PHASE 3, NON-INVESTIGATIONAL PRODUCT, MULTI COUNTRY COHORT STUDY TO DESCRIBE THE LONG-TERM SAFETY AND EFFECTIVENESS OF A PRIOR SINGLE-DOSE TREATMENT WITH INVESTIGATIVE GIROCTOCOGENE FITELPARVOVEC OR FIDANACOGENE ELAPARVOVEC IN PARTICIPANTS WITH HEMOPHILIA A OR HEMOPHILIA B, RESPECTIVELY",
"has_exemption": false,
"start_date": "2022-12-28",
"completion_date": "2040-02-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05849480",
"publication_url": "https://clinicaltrials.gov/study/NCT05849480",
"title": "A Phase I/II Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)",
"has_exemption": false,
"start_date": "2024-05-08",
"completion_date": "2040-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05620771",
"publication_url": "https://clinicaltrials.gov/study/NCT05620771",
"title": "Phase II Study Therasphere® (Yttrium-90) in Combination With Systemic Therapy in Patients With High-risk Hepatocellular Carcinoma",
"has_exemption": false,
"start_date": "2022-11-30",
"completion_date": "2040-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02689440",
"publication_url": "https://clinicaltrials.gov/study/NCT02689440",
"title": "Therapy of Early Chronic Phase Chronic Myelogenous Leukemia (CML) With Dasatinib and Venetoclax: A Phase II Study",
"has_exemption": false,
"start_date": "2016-02-19",
"completion_date": "2040-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT07073014",
"publication_url": "https://clinicaltrials.gov/study/NCT07073014",
"title": "A Phase 3, Open-Label, Long-Term Extension Study to Evaluate the Safety and Efficacy of Vosoritide in Children With Hypochondroplasia",
"has_exemption": false,
"start_date": "2025-06-20",
"completion_date": "2040-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "BioMarin Pharmaceutical",
"sponsor_slug": "biomarin-pharmaceutical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02760849",
"publication_url": "https://clinicaltrials.gov/study/NCT02760849",
"title": "WISP (Women Choosing Surgical Prevention)",
"has_exemption": false,
"start_date": "2016-05-02",
"completion_date": "2041-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT07095452",
"publication_url": "https://clinicaltrials.gov/study/NCT07095452",
"title": "Phase 2/3, Multicenter, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Subjects With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant",
"has_exemption": false,
"start_date": "2026-01-08",
"completion_date": "2042-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05962346",
"publication_url": "https://clinicaltrials.gov/study/NCT05962346",
"title": "Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion for Severe Left Congenital Diaphragmatic Hernia",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2043-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mauro H. Schenone",
"sponsor_slug": "mauro-h-schenone",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03486873",
"publication_url": "https://clinicaltrials.gov/study/NCT03486873",
"title": "A Multicenter, Open-label, Phase 3 Study to Evaluate the Long-term Safety and Efficacy in Participants Who Are Currently on Treatment or in Follow-up in Studies That Include Pembrolizumab",
"has_exemption": false,
"start_date": "2018-08-21",
"completion_date": "2043-08-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06281730",
"publication_url": "https://clinicaltrials.gov/study/NCT06281730",
"title": "Use of New Generation Fetoscopes in Pregnancies Affected by Fetal Diseases Amenable to Fetoscopy Therapy",
"has_exemption": false,
"start_date": "2024-03-23",
"completion_date": "2044-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06358638",
"publication_url": "https://clinicaltrials.gov/study/NCT06358638",
"title": "Sickle Cell Disease Transplant Using a Nonmyeloablative Approach: Adding Daratumumab for Patients With Anti-donor Red Cell AntibodY",
"has_exemption": false,
"start_date": "2024-04-03",
"completion_date": "2044-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's National Research Institute",
"sponsor_slug": "childrens-national-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01538056",
"publication_url": "https://clinicaltrials.gov/study/NCT01538056",
"title": "Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Juxtarenal Aortic Aneurysm: An Investigator Initiated Study",
"has_exemption": false,
"start_date": "2011-03-31",
"completion_date": "2045-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02917460",
"publication_url": "https://clinicaltrials.gov/study/NCT02917460",
"title": "Genomic Biorepository: Protocol for the Collection, Storage, Analysis, and Distribution of Biological Samples, Genomic and Clinical Data",
"has_exemption": false,
"start_date": "2016-07-31",
"completion_date": "2050-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rady Pediatric Genomics & Systems Medicine Institute",
"sponsor_slug": "rady-pediatric-genomics-systems-medicine-institute",
"status": "ongoing",
"is_pact": true,
"days_late": null
}
]
}